Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · October 09, 2023

Real-World Long-Term Outcome Analysis of Pyrotinib Therapy in Patients With HER2+ Metastatic Breast Cancer and Brain Metastasis

The Oncologist


Additional Info

The Oncologist
Long-term Outcome Analysis of Pyrotinib in Patients With HER2-Positive Metastatic Breast Cancer and Brain Metastasis: A Real-World Study
Oncologist 2023 Aug 17;[EPub Ahead of Print], X Liang, X Gui, Y Yan, L Di, X Liu, H Li, G Song

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading